STAT6 and non-small cell lung carcinoma: It has also been reported that STAT6 is a survival factor in human prostate [10] and unphosphorylated STAT6 increases the expression of COX-2, thereby protecting nonsmall cell lung cancer (NSCLC) against apoptosis [11, 12].